These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6117088)

  • 1. Failure of different neuropharmacologic manipulations to trigger a paradoxical rise of growth hormone after glucose administration in the dog.
    Betti R; Casanueva F; Vellani D; Cocchi D
    Pharmacol Res Commun; 1981 Sep; 13(8):743-53. PubMed ID: 6117088
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of the cholinergic system and growth hormone release in the dog: functional interactions with other neurotransmitters.
    Betti R; Casanueva FF; Cella SG; Müller EE
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):36-43. PubMed ID: 2982238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
    Imura H; Nakai Y; Matsukura S; Matsuyama H
    Horm Metab Res; 1973 Jan; 5(1):41-5. PubMed ID: 4706921
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of bromocriptine on plasma growth hormone and glucose tolerance in chronic renal failure.
    Kanis JA; Ledingham JG; Oliver DO; Walton RJ; Nairn IM
    Br Med J; 1976 Apr; 1(6014):879. PubMed ID: 1260390
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of adrenergic-blocking agents on plasma growth hormone. Response to L-5-hydroxytryptophan (5-HTP) in man.
    Nakai Y; Imura H
    Endocrinol Jpn; 1974 Dec; 21(6):493-7. PubMed ID: 4549429
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoreactive somatostatin in the hypothalamus and other regions of the rat brain: effects of insulin, glucose, alpha- or beta-blocker and L-dopa.
    Itoh M
    Endocrinol Jpn; 1979 Feb; 26(1):41-58. PubMed ID: 35344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine acts through alpha adrenergic and serotoninergic neurons to stimulate growth hormone secretion in the dog.
    Farris TS; Richards GE
    Life Sci; 1980 Oct; 27(14):1345-9. PubMed ID: 6255275
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute metabolic studies with trasicor in diabetics.
    McKechnie JK; Goldman A; Vinik AI
    S Afr Med J; 1969 Dec; ():Suppl:24-6. PubMed ID: 4906673
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of oral administration of 2-bromo-alpha-ergocriptine on blood glucose, serum IRI and HGH levels in normal subjects and diabetics (author's transl)].
    Matsushima Y; Makino H; Kanatsuka A; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1977 Jun; 53(6):743-51. PubMed ID: 913707
    [No Abstract]   [Full Text] [Related]  

  • 10. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J; Moraru E; Altszuler N
    Pharmacology; 1978; 17(3):138-48. PubMed ID: 704657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of bromocriptine on insulin secretion and glucose tolerance in patients with acromegaly.
    Feek CM; Bevan JS; Taylor S; Brown NS; Baird JD
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):473-8. PubMed ID: 7035013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chronic adrenergic blockade on the inhibition by epinephrine of growth hormone and insulin release in sheep.
    Hertelendy F; Takahashi K; Machlin LJ; Kipnis DM
    Horm Metab Res; 1970 Sep; 2(5):257-9. PubMed ID: 4400839
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation.
    Cocchi D; Gil-Ad I; Panerai AE; Locatelli V; Müller EE
    Neuroendocrinology; 1977; 24(1):1-13. PubMed ID: 23503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial and total lipodystrophy: changes in circulating sugar, free fatty acids, insulin and growth hormone following the administration of glucose and of insulin.
    Boucher BJ; Cohen RD; Frankel RJ; Mason AS; Broadley G
    Clin Endocrinol (Oxf); 1973 Apr; 2(2):111-26. PubMed ID: 4770267
    [No Abstract]   [Full Text] [Related]  

  • 16. Diurnal variation in glucose tolerance and in insulin secretion in man.
    Carroll KF; Nestel PJ
    Diabetes; 1973 May; 22(5):333-48. PubMed ID: 4700047
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of pseudopregnancy in the bitch with prolactin inhibitors metergoline and bromocriptine].
    Grünau B; Nolte I; Hoppen HO
    Tierarztl Prax; 1996 Apr; 24(2):149-55. PubMed ID: 8650684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suckling behavior in neonatal rats: psychopharmacological investigations.
    Spear LP; Ristine LA
    J Comp Physiol Psychol; 1982 Apr; 96(2):244-55. PubMed ID: 6121827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of autonomic blocking agents on growth hormone, insulin, free fatty acids and glucose in baboons.
    Werrbach JH; Gale CC; Goodner CJ; Conway MJ
    Endocrinology; 1970 Jan; 86(1):77-82. PubMed ID: 4982192
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.